Evidence map›Paper›PMID 40155995›Full record

ArticleBMC medicine2025

A pilot cluster-controlled trial of interventions to improve detection of depression in primary healthcare in Ethiopia.

Abebaw Fekadu, Barkot Milkias, Rahel Birhane, Bethlehem Tekola, Mahlet Yared, Tigist Eshetu, Tomas Getahun, Heidi Lempp, Andre Tylee, Merga Belina and 12 more

Abstract readControlled Clinical Trial
In one paragraph

Article in BMC medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Abebaw FekaduCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia. abebaw.fekadu@aau.edu.et.
Barkot MilkiasWHO Collaborating Center for Mental Health Research and Capacity Building, Department of Psychiatry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Rahel BirhaneCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia.
Bethlehem TekolaHealth Service and Population Research Department, Institute of Psychiatry, Psychology, and Neuroscience, Centre for Global Mental Health, King's College London, London, UK.
Mahlet YaredWHO Collaborating Center for Mental Health Research and Capacity Building, Department of Psychiatry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Tigist EshetuCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia.
Tomas GetahunCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia.
Heidi LemppDepartment of Inflammation Biology, Centre for Rheumatic Diseases, Faculty of Life Sciences and Medicine, King's College London, Cutcombe Road, 10, Cutcombe Rd, Weston Education Centre, London, SE5 9RJ, UK.
Andre TyleeHealth Service and Population Research Department, Institute of Psychiatry, Psychology, and Neuroscience, Centre for Global Mental Health, King's College London, London, UK.
Merga BelinaCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia.
Girmay MedhinCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia.
Kassahun HabtamuSchool of Psychology, College of Education and Behavioral Studies, Addis Ababa University, Addis Ababa, Ethiopia.
Atalay AlemWHO Collaborating Center for Mental Health Research and Capacity Building, Department of Psychiatry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Crick LundHealth Service and Population Research Department, Institute of Psychiatry, Psychology, and Neuroscience, Centre for Global Mental Health, King's College London, London, UK.
Inge PetersenCentre for Rural Health, School of Nursing and Public Health, University of Kwazulu-Natal, Howard College, Mazisi Kunene Road, Durban, 4001, South Africa.
Graham ThornicroftHealth Service and Population Research Department, Institute of Psychiatry, Psychology, and Neuroscience, Centre for Global Mental Health, King's College London, London, UK.
Anthony J CleareCentre for Affective Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Rosie MaystonHealth Service and Population Research Department, Institute of Psychiatry, Psychology, and Neuroscience, Centre for Global Mental Health, King's College London, London, UK.
Esubalew A AssefaCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia.
Mekdes DemissieCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia.
Charlotte HanlonDivision of Psychiatry, Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK.
Martin J PrinceHealth Service and Population Research Department, Institute of Psychiatry, Psychology, and Neuroscience, Centre for Global Mental Health, King's College London, London, UK.

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundThe low recognition of depression in primary healthcare (PHC) remains a major obstacle to rendering adequate care for people with depression globally. This study aimed to evaluate the feasibility and potential benefit of a contextually developed multicomponent and multilevel intervention to improve the identification of depression in PHC.

methodsA pilot, four-arm, parallel-group, cluster, non-randomised controlled trial was conducted in a predominantly rural district in Ethiopia. The active interventions were allocated to three PHC facilities: (1) a core multicomponent intervention focusing on providers-a manualised training package along with system intervention (mobile application, posters, quality improvement and supervision) (Level-I/Arm I), (2) Level-I intervention plus a 4-item screening questionnaire administered by triage nurses (Level-II/Arm II), (3) Level-II intervention plus service user awareness raising (Level-III/Arm III). In the control facility, standard integrated mental healthcare (care by providers trained in the standard WHO mhGAP intervention guide) was available. The outcomes were the identification of depression and the feasibility and acceptability of implementation by PHC clinicians. Quantitative and qualitative data were collected post-intervention. Descriptive analysis and thematic analysis were used to analyse the data.

resultsA total of 21 providers (14 clinicians and 7 triage nurses) and 1659 adult outpatients participated in the study. Overall, 116 outpatients (7.0%) received a diagnosis of depression by PHC clinicians. Detection of depression was significantly better in the active intervention arms combined: 8.3% (n = 115/1380) vs. 0.4% (n = 1/279) in the control arm. Level-II and Level-III intervention arms had significantly higher rates of detection (10.1% Level II, 9.2% Level III) compared with Level I (5.2%); however, there was no significant difference between Level-II and Level-III. The interventions demonstrated very good acceptability, feasibility and appropriateness although screening, which was included in the Level II and Level III intervention arms, had relatively lower acceptability and an overall low positive predictive value.

conclusionsThe tested interventions hold good promise of enhancing the identification of depression in PHC, with excellent feasibility and acceptability parameters. Although screening has good potential, implementation in routine care requires further optimisation and evaluation.

trial registrationTrial ID: PACTR202206723109626. Registration date: 21 June 2022. Retrospectively registered.

Indexed as

DepressionPrimary Health CareAdultEthiopiaFeasibility StudiesFemaleHealth PersonnelHumansMaleMass ScreeningMiddle AgedPilot ProjectsSurveys and QuestionnairesYoung AdultAcceptabilityAfricaDepressionDetectionFeasibilityInterventionPilot trialPrimary healthcare

Identifiers

PMID40155995
PMCPMC11951514

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.